FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Bipartisan Patent Coordination Bill In

A bipartisan group of five Senate Judiciary Committee members introduces legislation to establish an FDA/Patent and Trademark Office task force to imp...

FDA General

FDA to Cut Another 3,500 Employees Under HHS Plan

HHS says FDA will lose about 3,500 (18%) of its 19,000 full-time employees under a just-announced reductions in force plan to consolidate activities a...

latest-news-card-1
Medical Devices

FDA Likely to Miss Review Deadlines: Staff

An exclusive Reuters report says FDA is likely to miss medical device user fee deadlines due to staff shortages from two rounds of cuts mandated by th...

latest-news-card-1
Human Drugs

Solenos Vykat OKd for Prader-Willi Hyperphagia

FDA approves a Soleno Therapeutics NDA for Vykat XR (diazoxide choline) extended-release tablets for treating hyperphagia in individuals with Prader-W...

latest-news-card-1
Medical Devices

Prometheus, Owner Paying $550,000 for False Claims

The Department of Justice reaches a settlement in which medical device company Prometheus and its owner agree to pay $550,000 to resolve False Claims ...

latest-news-card-1
Human Drugs

Merck Seeks Approval for Subcutaneous Keytruda

FDA accepts a Merck BLA for a subcutaneous formulation of Keytruda (pembrolizumab) for its use across all previously approved solid tumor indications....

latest-news-card-1
Human Drugs

Fresenius Prolia, Xgeva Biosimilars Approved

FDA approves Fresenius Kabi BLAs for biosimilar denosumab products that reference Amgens Prolia and Xgeva.

Medical Devices

FDA Clears Vasorum Vascular Closure Device

FDA clears a Vasorum 510(k) for the Celt ACD Plus vascular closure device.

FDA General

Makary Wins Senate Floor Vote on FDA Confirmation

A Senate floor vote moves Marty Makary one step closer to becoming the next FDA commissioner.

latest-news-card-1
Human Drugs

CGMP Violations at Chinas Yangzhou Sion

FDA warns Chinas Yangzhou Sion Commodity Co. about CGMP violations in its manufacturing of finished drugs.